Deep Learning

926 articles found

Poolside Breaks 18-Month Silence With Open-Source AI Model That Rivals Chinese Competitors At a Fraction of the Size

Poolside Breaks 18-Month Silence With Open-Source AI Model That Rivals Chinese Competitors At a Fraction of the Size

Jul 22, 2026
Forbes

Poolside emerges from 18 months of silence with its open-source AI model Laguna, which rivals top American and Chinese competitors despite being a fraction of their size, while the startup also holds an unreported stake in Fluidstack now worth roughly $860 million following the neocloud's $830 million raise.

AI Slashes Drug Development Costs by 70% But Faces Scrutiny as No AI-Discovered Drug Has Yet Won FDA Approval

AI Slashes Drug Development Costs by 70% But Faces Scrutiny as No AI-Discovered Drug Has Yet Won FDA Approval

Jul 21, 2026
Axios

AI is slashing drug development costs by up to 70% and driving a projected $1 billion surge in new biopharma spending, but critics warn that no AI-discovered drug has yet received FDA approval, and the industry's notorious 90% failure rate may persist if human biological variability isn't properly addressed before …

Page 1 of 93
Next
Showing 1 - 10 of 926 articles